Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Automatically generated smartphone data and subjective stress in healthy individuals - a pilot study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association between Mental Disorders and Subsequent Medical Conditions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Forecasting Mood in Bipolar Disorder From Smartphone Self-assessments: Hierarchical Bayesian Approach

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The effect of erythropoietin on electroconvulsive stimulation induced cognitive impairment in rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in animal models of acute and chronic neurodegenerative conditions and in patients with cognitive decline.
OriginalsprogEngelsk
TidsskriftPsychopharmacology
Vol/bind219
Udgave nummer3
Sider (fra-til)687-98
Antal sider12
ISSN0033-3158
DOI
StatusUdgivet - 2012

ID: 36475096